ATC Group: A03AA04 Mebeverine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A03AA04 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Drugs for functional gastrointestinal disorders
3
DRUGS FOR FUNCTIONAL BOWEL DISORDERS
4
Synthetic anticholinergics, esters with tertiary amino group
5
A03AA04
Mebeverine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
0.3 g

Active ingredients in A03AA04

Active Ingredient
Description

Mebeverine is a musculotropic antispasmodic with a direct action on the smooth muscle of the gastrointestinal tract, relieving spasm without affecting normal gut motility.

Medicines in this ATC group

Drug
Countries

United Kingdom

Ecuador

South Africa

Australia

Australia Austria Ireland New Zealand South Africa ...

Ecuador Germany Netherlands

Brazil Cyprus Ecuador Estonia France ...

Hong Kong Singapore

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK